Galderma Group AG - SIC # 2830 -

Ticker Exchange SIC # Website Latest Ticker
GALDY Over the counter 2830 www.galderma.com

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Galderma Group AG

Galderma Announces First Patient Enrollment in Study to Assess Nemolizumab in Adults With Chronic Pruritus of Unknown Origin - Dec 10th, 2025 11:00 pm
L’Oréal to raise stake in Galderma to 20% - Dec 9th, 2025 2:52 am
Is It Too Late to Consider Galderma After Its 61% Surge in 2025? - Dec 9th, 2025 12:08 am
L’Oréal Doubles Stake in Swiss Skincare Company Galderma - Dec 8th, 2025 9:21 am
L’Oréal Is Increasing Stake in Galderma to 20 Percent - Dec 8th, 2025 2:48 am
Evaluating Galderma Group (SWX:GALD) After a 60% Year-to-Date Rally and Strong Shareholder Returns - Dec 8th, 2025 1:08 am
EQT agrees to sale of shares in Galderma Group AG to L'Oréal S.A. - Dec 8th, 2025 12:03 am
Galderma Welcomes Increased Equity Investment From L’Oréal - Dec 7th, 2025 11:05 pm
L’ORÉAL GROUPE TO REINFORCE ITS STRATEGIC INVESTMENT IN GALDERMA WITH AN ADDITIONAL 10% BRINGING ITS TOTAL PARTICIPATION TO 20% - Dec 7th, 2025 11:05 pm
Galderma Opens up New Chapter for Sculptra® with MDR Certification and New Expanded Indication for Body - Dec 4th, 2025 11:00 pm
Galderma Secures ‘BBB’ Credit Rating With Positive Outlook from S&P Global Ratings - Dec 3rd, 2025 11:00 pm
How the Story Around Galderma Is Evolving with Analyst Upgrades and Growth Momentum - Nov 17th, 2025 1:13 am
ASDS 2025: Compelling New Data on Restylane, Sculptra and Relfydess Highlight Galderma’s Innovative Injectable Aesthetics Portfolio and Pipeline - Nov 16th, 2025 11:00 pm
Galderma Receives U.S. FDA Approval for Restylane® Lyft™ for the Enhancement of the Chin Profile - Nov 4th, 2025 11:00 pm
EQT completes sale of shares in Galderma Group AG - Oct 30th, 2025 10:56 am
Galderma Delivers Record Net Sales of 3.737 Billion USD in the First Nine Months of 2025 and 15.0% Year-on-Year Growth at Constant Currency, Raises Full-Year Guidance - Oct 22nd, 2025 11:00 pm
Galderma Group AG's (VTX:GALD) Intrinsic Value Is Potentially 78% Above Its Share Price - Oct 2nd, 2025 7:34 am
AMWC Dubai: Galderma Demonstrates Injectable Aesthetics Leadership Through Updates on Its Scientific Innovations and Community Education - Sep 23rd, 2025 11:00 pm
Galderma Launches Transformative Skincare Segment With Cetaphil’s New Skin Activator Hydrating & Firming Line, in Partnership With Actor and Filmmaker Mariska Hargitay - Sep 17th, 2025 11:00 pm
Galderma’s Groundbreaking Real-World Study Reveals the Biological Toll of Modern Living and Urban Environments on Sensitive Skin - Sep 16th, 2025 11:00 pm